For more insights on the forecast market size and historic data (2018 - 2022) - Download Free sample report in a minutes Forecast period 2024-2028 Base Year 2023 Historic Data 2018 - 2022 Segment Covered Application (Clinical diagnostics and Research), Product (Reagents, kits, and Analyzers), and Geography (North America, Europe, Asia, and Rest of World (ROW)) Region Covered North America, Europe, Asia, and Rest of World (ROW) Key companies profiled ALPCO, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Danaher Corp.
, Enzo Biochem Inc., Merck KGaA, MP BIOMEDICALS, OriGene Technologies Inc., PerkinElmer Inc, Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc.
Key Market Trends Fueling Growth The radioimmunoassay market is experiencing a significant trend towards automation and system integration. Laboratories are adopting automated platforms, such as Siemens Healthineers AG's IMMULITE 2000 XPi Immunoassay System and Beckman Coulter Inc.'s DxCi 800 Immunoassay System, which offer walk-away capabilities and seamless integration with laboratory information management systems and robotic sample handling.
This shift enhances productivity, reduces turnaround times, and minimizes manual errors, driving market growth. The Radioimmunoassay market is currently experiencing significant growth, driven by the increasing demand for diagnostic tests in various industries. Somatostatin receptors, Delphinidins, and Cardiolipins are k.
